Minerva Neurosciences
NERV
20 hedge funds and large institutions have $14.9M invested in Minerva Neurosciences in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
37% more capital inflows, than outflows
Capital inflows: $218K | Capital outflows: $160K
0.18% more ownership
Funds ownership: 34.38% → 34.56% (+0.18%)
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$143K |
| 2 |
Renaissance Technologies
New York
|
+$74.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$732 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$69 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74.5K |
| 2 |
Morgan Stanley
New York
|
-$41.8K |
| 3 |
UBS O'Connor
Chicago,
Illinois
|
-$30.6K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$7.88K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4.75K |
NERV Hedge Fund Activity: Q4 2023 in Review
20 of the 6,878 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2023, worth a combined $14.9M — down 10% from $16.6M a quarter earlier.
Fund positioning in NERV was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 4 trimmed.
The largest buyer was Northern Trust, opening a new position worth an estimated $143K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $74.5K sold.
- 20 institutional investors held Minerva Neurosciences (NERV) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $14.9M of Minerva Neurosciences stock for Q4 2023, down 10% quarter-over-quarter.
- 2 funds opened new Minerva Neurosciences positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest Minerva Neurosciences buyer in Q4 2023 was Northern Trust, an estimated $143K added.
- The largest Minerva Neurosciences seller in Q4 2023 was Susquehanna International Group, an estimated $74.5K sold.
Based on aggregated 13F filings for Q4 2023.